Financhill
Back

Bristol-Myers Squibb Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
43

BMY
Bristol-Myers Squibb

Last Price:
55.94
Seasonality Move:
1.69%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Bristol-Myers Squibb Price Quote

$55.94
-0.01 (0.88%)
(Updated: November 6, 2024 at 4:35 AM ET)

Bristol-Myers Squibb Key Stats

Sell
43
Bristol-Myers Squibb (BMY) is a Sell

Day range:
$54.72 - $56.28
52-week range:
$39.35 - $56.28
Dividend yield:
4.29%
P/E ratio:
14.49
P/S ratio:
2.39
P/B ratio:
6.62%

Volume:
9.2M
Avg. volume:
10.8M
1-year change:
5.93%
Market cap:
$113.5B
Revenue:
$45B
EPS:
$-3.59

How Much Does Bristol-Myers Squibb Make?

Is Bristol-Myers Squibb Growing As A Company?

  • What Is Bristol-Myers Squibb's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Bristol-Myers Squibb's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.35%

Bristol-Myers Squibb Stock Price Performance

What Is Bristol-Myers Squibb 52-Week High & Low?

Bristol-Myers Squibb Price To Free Cash Flow

Is It Risky To Buy Bristol-Myers Squibb?

Is Bristol-Myers Squibb Cash Flow Positive?

  • What Is BMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $15B
  • What Is Bristol-Myers Squibb’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.7B
  • What Is Bristol-Myers Squibb’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$22.5B

Bristol-Myers Squibb Return On Invested Capital

  • Is Management Doing A Good Job?
    BMY return on invested capital is -10.53%
  • What Is Bristol-Myers Squibb Return On Assets?
    ROA measures how assets are converting to revenues and is -7.66%
  • What Is BMY Return On Equity?
    ROE is a measure of profitability and is -33.18%

Bristol-Myers Squibb Earnings Date & Stock Price

Bristol-Myers Squibb Competitors

Bristol-Myers Squibb Dividend Yield

Bristol-Myers Squibb Analyst Estimates

YoY Growth Past Surprise
EPS: -35.48% 19.98%
Revenue: 8.44% 5.75%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 18
Sell Recommendations: 1
Price Target: 54.21
Downside from Last Price: -3.12%

Major Shareholders

  • How many BMY shares are owned by institutional investors?
    2.4B BMY shares are owned by institutional investors
  • How many BMY shares are owned by insiders?
    6.5M BMY shares are owned by insiders